this thing is going up like it owns the market, yet there will be competition and so forth. unreal valuation. there are so many smsf's out there that dont need class.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025